Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Marth

Showing results (31-40 of 237) with videos related to

Pageof 24
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 11, 2002
Prognostic significance of signal transducer and activator of transcription 1 activation in breast cancerAndreas Widschwendter, Sibylle Tonko-Geymayer, Thomas Welte, et al.
Breast (Edinburgh, Scotland)|December 9, 2003
Evaluation of bone marrow in breast cancer patients: prediction of clinical outcome and response to therapyStephan Braun, Florian D Vogl, Wolfgang Janni, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 15, 2019
Clinical pathways of recovery after surgery for advanced ovarian/tubal/peritoneal cancer: an NSGO-MaNGO international survey in collaboration with AGO-a focus on surgical aspectsElisa Piovano, Annamaria Ferrero, Paolo Zola, et al.
Archives of Gynecology and Obstetrics|September 24, 2021
The impact of COVID-19 pandemic on the rate of newly diagnosed gynecological and breast cancers: a tertiary center perspectiveKatharina Knoll, Elisabeth Reiser, Katharina Leitner, et al.
Gynecologic Oncology|July 7, 2010
High IL-12 p35 and IL-23 p19 mRNA expression is associated with superior outcome in ovarian cancerAnna Maria Wolf, Holger Rumpold, Daniel Reimer, et al.
Anticancer Research|November 27, 2008
Activated p38-MAPK and gemcitabine sensitivity in recurrent ovarian cancerRenate Klotz, Alain Gustave Zeimet, Daniel Reimer, et al.
Journal of Comparative Effectiveness Research|November 2, 2017
Development of a novel prognostic score for breast cancer patients using mRNA expression of CHAC1Beate Jahn, Marjan Arvandi, Ursula Rochau, et al.
Cancer Letters|December 4, 2003
Human papillomavirus DNA in sera of cervical cancer patients as tumor markerAndreas Widschwendter, Anya Blassnig, Annemarie Wiedemair, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 18, 2025
Real-world treatment patterns and clinical outcomes in patients with advanced or recurrent endometrial cancer re-challenged with platinum-based chemotherapy in EuropeVimalanand Prabhu, Sneha Kelkar, Jingchuan Zhang, et al.
BMC Public Health|February 11, 2011
Introduction of organised mammography screening in Tyrol: results of a one-year pilot phaseWilli Oberaigner, Wolfgang Buchberger, Thomas Frede, et al.
Pageof 24

Showing results (31-40 of 237) with videos related to

Sort By:
Pageof 24
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 11, 2002
Prognostic significance of signal transducer and activator of transcription 1 activation in breast cancerAndreas Widschwendter, Sibylle Tonko-Geymayer, Thomas Welte, et al.
Breast (Edinburgh, Scotland)|December 9, 2003
Evaluation of bone marrow in breast cancer patients: prediction of clinical outcome and response to therapyStephan Braun, Florian D Vogl, Wolfgang Janni, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 15, 2019
Clinical pathways of recovery after surgery for advanced ovarian/tubal/peritoneal cancer: an NSGO-MaNGO international survey in collaboration with AGO-a focus on surgical aspectsElisa Piovano, Annamaria Ferrero, Paolo Zola, et al.
Archives of Gynecology and Obstetrics|September 24, 2021
The impact of COVID-19 pandemic on the rate of newly diagnosed gynecological and breast cancers: a tertiary center perspectiveKatharina Knoll, Elisabeth Reiser, Katharina Leitner, et al.
Gynecologic Oncology|July 7, 2010
High IL-12 p35 and IL-23 p19 mRNA expression is associated with superior outcome in ovarian cancerAnna Maria Wolf, Holger Rumpold, Daniel Reimer, et al.
Anticancer Research|November 27, 2008
Activated p38-MAPK and gemcitabine sensitivity in recurrent ovarian cancerRenate Klotz, Alain Gustave Zeimet, Daniel Reimer, et al.
Journal of Comparative Effectiveness Research|November 2, 2017
Development of a novel prognostic score for breast cancer patients using mRNA expression of CHAC1Beate Jahn, Marjan Arvandi, Ursula Rochau, et al.
Cancer Letters|December 4, 2003
Human papillomavirus DNA in sera of cervical cancer patients as tumor markerAndreas Widschwendter, Anya Blassnig, Annemarie Wiedemair, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 18, 2025
Real-world treatment patterns and clinical outcomes in patients with advanced or recurrent endometrial cancer re-challenged with platinum-based chemotherapy in EuropeVimalanand Prabhu, Sneha Kelkar, Jingchuan Zhang, et al.
BMC Public Health|February 11, 2011
Introduction of organised mammography screening in Tyrol: results of a one-year pilot phaseWilli Oberaigner, Wolfgang Buchberger, Thomas Frede, et al.
Pageof 24